Subgroups and Heterogeneity in Cost-Effectiveness Analysis

被引：0

作者：

Mark Sculpher

机构：

[1] University of York,Centre for Health Economics and NICE Decision Support Unit

来源：

PharmacoEconomics | 2008年 / 26卷

关键词：

Cost Effectiveness; Alteplase; Health Gain; Relative Treatment Effect; Public Preference;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The National Institute for Health and Clinical Excellence (NICE) is required to consider cost effectiveness when issuing guidance about the use of health technologies within the UK NHS. Cost effectiveness is a means of supporting a system objective of maximizing population health gain from the available budget.

引用

页码：799 / 806

页数：7

共 50 条

[1] Subgroups and heterogeneity in cost-effectiveness analysis
Sculpher, Mark
[J]. PHARMACOECONOMICS, 2008, 26 (09) : 799 - 806
[2] Using causal forests to assess heterogeneity in cost-effectiveness analysis
Bonander, Carl
Svensson, Mikael
[J]. HEALTH ECONOMICS, 2021, 30 (08) : 1818 - 1832
[3] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
HIMMELSTEIN, DU
WOOLHANDLER, S
BOR, DH
[J]. CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
[4] The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application
Espinoza, Manuel A.
Manca, Andrea
Claxton, Karl
Sculpher, Mark J.
[J]. MEDICAL DECISION MAKING, 2014, 34 (08) : 951 - 964
[5] COST-EFFECTIVENESS ANALYSIS
GANIATS, TG
[J]. PRIMARY CARE, 1995, 22 (02): : 307 - 318
[6] Cost-effectiveness analysis
Stein, Sherman C.
Malhotra, Neil R.
Burnett, Mark G.
[J]. JOURNAL OF NEUROSURGERY-SPINE, 2014, 20 (04) : 474 - 474
[7] THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION
Espinoza, M.
Manca, A.
Claxton, K.
Sculpher, M. J.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A241 - A241
[8] COST-EFFECTIVENESS ANALYSIS
BALAKRISHNA, S
[J]. JOURNAL OF RURAL DEVELOPMENT, 1992, 11 (05) : 701 - 703
[9] Cost-effectiveness analysis
Yates, BT
[J]. EVALUATION AND PROGRAM PLANNING, 2002, 25 (02) : 201 - 202
[10] (HOW) SHOULD COST-EFFECTIVENESS ANALYSIS ACCOMMODATE HETEROGENEITY IN PATIENT PREFERENCES?
Hawkins, N.
Szabo, S.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S469 - S469

← 1 2 3 4 5 →